Prognostic Factors in Extensive-Stage Small Cell Lung Cancer (SCLC)

被引：0
|
作者：
De Almeida, S. B. [1 ]
Vitorino, M. [1 ]
Goncalves, S. [1 ]
机构：
[1] Hosp Prof Doutor Fernando Fonseca, EPE, Amadora, Portugal
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO01.44
引用
收藏
页码：S34 / S35
页数：2
相关论文
共 50 条
  • [1] INTENSIVE CHEMOTHERAPY FOR EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER (SCLC)
    OSOBA, D
    [J]. CANCER INVESTIGATION, 1992, 10 (02) : 185 - 186
  • [2] Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer
    Tomoya Fukui
    Michiko Itabashi
    Mikiko Ishihara
    Yasuhiro Hiyoshi
    Masashi Kasajima
    Satoshi Igawa
    Jiichiro Sasaki
    Noriyuki Masuda
    [J]. BMC Cancer, 16
  • [3] Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer
    Fukui, Tomoya
    Itabashi, Michiko
    Ishihara, Mikiko
    Hiyoshi, Yasuhiro
    Kasajima, Masashi
    Igawa, Satoshi
    Sasaki, Jiichiro
    Masuda, Noriyuki
    [J]. BMC CANCER, 2016, 16
  • [4] Immunotherapy in Extensive-Stage Small Cell Lung Cancer
    El Sayed, Rola
    Blais, Normand
    [J]. CURRENT ONCOLOGY, 2021, 28 (05) : 4093 - 4108
  • [5] Prognostic impact of Neutrophil-to-Lymphocyte Ratio (NLR) For Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
    Ishihara, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S684 - S685
  • [6] The prognostic values of prognostic nutritional index in extensive-stage small-cell lung cancer
    Bahceci, Aykut
    Sedef, Ayse Kotek
    Isik, Deniz
    [J]. ANTI-CANCER DRUGS, 2022, 33 (01) : E534 - E540
  • [7] Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)
    Xiaoting Ma
    Shan Wang
    Yujian Zhang
    Huamin Wei
    Jing Yu
    [J]. Journal of Cancer Research and Clinical Oncology, 2021, 147 : 593 - 606
  • [8] Carboplatin in Combination with Bendamustine in Previously Untreated Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
    Wolf Köster
    G. Stamatis
    A. Heider
    K. Avramidis
    H. Wilke
    J.A. Koch
    M. Stahl
    [J]. Clinical Drug Investigation, 2004, 24 : 611 - 618
  • [9] Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
    Gadgeel, Shirish M.
    Pennell, Nathan A.
    Fidler, Mary Jo
    Halmos, Balazs
    Bonomi, Philip
    Stevenson, James
    Schneider, Bryan
    Sukari, Ammar
    Ventimiglia, Jaclyn
    Chen, Wei
    Galasso, Cathy
    Wozniak, Antoinette
    Boerner, Julie
    Kalemkerian, Gregory P.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : 1393 - 1399
  • [10] Carboplatin in combination with bendamustine in previously untreated patients with extensive-stage small cell lung cancer (SCLC)
    Köster, W
    Stamatis, G
    Heider, A
    Avramidis, K
    Wilke, H
    Koch, JA
    Stahl, M
    [J]. CLINICAL DRUG INVESTIGATION, 2004, 24 (10) : 611 - 618
12345